Cargando…

Neutralizing antibodies against Mayaro virus require Fc effector functions for protective activity

Despite causing outbreaks of fever and arthritis in multiple countries, no countermeasures exist against Mayaro virus (MAYV), an emerging mosquito-transmitted alphavirus. We generated 18 neutralizing mAbs against MAYV, 11 of which had “elite” activity that inhibited infection with EC(50) values of &...

Descripción completa

Detalles Bibliográficos
Autores principales:	Earnest, James T., Basore, Katherine, Roy, Vicky, Bailey, Adam L., Wang, David, Alter, Galit, Fremont, Daved H., Diamond, Michael S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781005/ https://www.ncbi.nlm.nih.gov/pubmed/31337735 http://dx.doi.org/10.1084/jem.20190736

Ejemplares similares

The mechanistic basis of protection by non-neutralizing anti-alphavirus antibodies
por: Earnest, James T., et al.
Publicado: (2021)

Enhancing the therapeutic activity of hyperimmune IgG against chikungunya virus using FcγRIIIa affinity chromatography
por: Fox, Julie M., et al.
Publicado: (2023)

A molecular understanding of alphavirus entry
por: Holmes, Autumn C., et al.
Publicado: (2020)

Differences in HPV-specific antibody Fc-effector functions following Gardasil® and Cervarix® vaccination
por: Roy, Vicky, et al.
Publicado: (2023)

Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
por: Mackin, Samantha R., et al.
Publicado: (2022)

HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodies
por: Richardson, Simone I., et al.
Publicado: (2018)

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection
por: Winkler, Emma S., et al.
Publicado: (2021)

Extra-Neutralizing FcR-Mediated Antibody Functions for a Universal Influenza Vaccine
por: Boudreau, Carolyn M., et al.
Publicado: (2019)

Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
por: Brown, Eric P., et al.
Publicado: (2017)

Structural basis of West Nile virus neutralization by a therapeutic antibody
por: Nybakken, Grant E., et al.
Publicado: (2005)

Coordinated Fc-effector and neutralization functions in HIV-infected children define a window of opportunity for HIV vaccination
por: Nduati, Eunice W., et al.
Publicado: (2021)

A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes
por: Thompson, Bruce S., et al.
Publicado: (2009)

Vector induced skewing of antibody Fc-effector functions
por: Chung, A, et al.
Publicado: (2012)

Structure of Venezuelan equine encephalitis virus in complex with the LDLRAD3 receptor
por: Basore, Katherine, et al.
Publicado: (2021)

Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein
por: Kim, Arthur S., et al.
Publicado: (2018)

Potent Dengue Virus Neutralization by a Therapeutic Antibody with Low Monovalent Affinity Requires Bivalent Engagement
por: Edeling, Melissa A., et al.
Publicado: (2014)

Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccination
por: Boudreau, Carolyn M., et al.
Publicado: (2023)

Broadly neutralizing monoclonal antibodies protect against multiple tick-borne flaviviruses
por: VanBlargan, Laura A., et al.
Publicado: (2021)

Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus
por: Doyle, Michael P., et al.
Publicado: (2022)

Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
por: Gunn, Bronwyn M., et al.
Publicado: (2021)

Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
por: Zhang, Ali, et al.
Publicado: (2022)

Neutralising antibodies for Mayaro virus in Pantanal, Brazil
por: Pauvolid-Corrêa, Alex, et al.
Publicado: (2015)

Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope
por: Austin, S. Kyle, et al.
Publicado: (2012)

Associations Between Antibody Fc-Mediated Effector Functions and Long-Term Sequelae in Ebola Virus Survivors
por: Paquin-Proulx, Dominic, et al.
Publicado: (2021)

Antibodies targeting epitopes on the cell-surface form of NS1 protect against Zika virus infection during pregnancy
por: Wessel, Alex W., et al.
Publicado: (2020)

Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis
por: Lu, Lenette L, et al.
Publicado: (2020)

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
por: VanBlargan, Laura, et al.
Publicado: (2021)

Fc-Effector-Independent in vivo Activity of a Potent Influenza B Neuraminidase Broadly Neutralizing Antibody
por: Khalil, Ahmed M., et al.
Publicado: (2023)

IgG3 enhances neutralization potency and Fc effector function of an HIV V2-specific broadly neutralizing antibody
por: Richardson, Simone I., et al.
Publicado: (2019)

HIV Broadly Neutralizing Antibodies Expressed as IgG3 Preserve Neutralization Potency and Show Improved Fc Effector Function
por: Richardson, Simone I., et al.
Publicado: (2021)

A requirement for FcγR in antibody-mediated bacterial toxin neutralization
por: Abboud, Nareen, et al.
Publicado: (2010)

LDLRAD3 is a receptor for Venezuelan equine encephalitis virus
por: Ma, Hongming, et al.
Publicado: (2020)

Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection
por: Muenchhoff, M., et al.
Publicado: (2020)

Vaccine-induced antibody Fc-effector functions in humans immunized with a combination Ad26.RSV.preF/RSV preF protein vaccine
por: Bartsch, Yannic C., et al.
Publicado: (2023)

Protective immunity by an engineered DNA vaccine for Mayaro virus
por: Choi, Hyeree, et al.
Publicado: (2019)

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
por: Shrestha, Bimmi, et al.
Publicado: (2010)

Selective SARS-CoV2 BA.2 escape of antibody Fc/Fc-receptor interactions
por: Bartsch, Yannic C., et al.
Publicado: (2023)

Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
por: van der Horst, Hilma J., et al.
Publicado: (2020)

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
por: Hassan, Ahmed O., et al.
Publicado: (2020)

Requirement of Fc-Fc Gamma Receptor Interaction for Antibody-Based Protection against Emerging Virus Infections
por: Keeler, Shamus P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fh3he7lvo657jdemq1nnbgmqnp